The sheet contains cardiomyocytes and is derived from mesenchymal stem cells obtained from the bone marrow fluid of healthy donors, followed the transformation into cardiomyocytes and cell expansion. Clinical trials were done in about 25 cases.
Terumo news release, August 19, 2015
Terumo and JCR Pharmaceuticals hope for approval of “heart sheet” in September 2015